Guest guest Posted August 27, 2011 Report Share Posted August 27, 2011 Greetings, Within we provide a list of lymphomation: news items and reports. === News and Reports: www.lymphomation.org/current.htm OR www.facebook.com/lymphomation.PAL (requires a facebook account) === A topical/tropical feature from ACS: Coping With Cancer After a Natural Disaster === Survivorship topics MD: Top 10 musts for your hospital visit NCCN: Oral Chemotherapy: Potentials and Misconceptions UCSF: Study Shows Greater Impact of Chemo on Fertility Live Science: Nurses Exposed to Toxic Cancer Drugs, Study Finds MD: Taking care of yourself sometimes means being selfish (For the caregivers out there!) MD: Patients need to contribute to help their doctors NEJM: The Doctor's Dilemma - What Is " Appropriate " Care? Oncology Times: VIEW FROM THE OTHER SIDE OF THE STETHOSCOPE: " It's Okay " Information Week: Patients say they want more e-mail-based communications with their clinicians. Despite obstacles, momentum is growing. Oncology Times: Stopping Time. Excellent essay by Dr. Harpham (end of life issues) === Reports / Background ASCO POST: Combined Therapy Produces Good Outcomes in Primary Testicular Diffuse Large B-cell Lymphoma ODAC: Recommends Accelerated Approval for Brentuximab CURE: New drug for two types of lymphoma NCCN: Updated patient info on NHL PubMED: Interim (mid-treatment) PET Not Justified In DLBCL During First Line Immuno-Chemotherapy AM J Hematology: Follicular lymphoma: 2011 update on diagnosis and management Cochrane: Comparison of chemotherapy including escalated BEACOPP vs chemotherapy including ABVD for patients with early unfavorable or advanced stage Hodgkin lymphoma ISRN Hematology: A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma Comment: Speaks to the need for routine referral to clinical trials for patients with PTCL NOS. Blood: Bazarbachi, Suarez, Fields,and Hermine How I treat adult T-cell leukemia/lymphoma NCCN: Understanding Your Risk of Developing Secondary Cancers Consortium for Improving Survival of Lymphoma: Multicenter retrospective analysis of 581 patients with primary intestinal non-Hodgkin lymphoma ASH: The 2008 WHO classification of lymphomas: implications for clinical practice and translational research UCLA: Results of medication studies in top medical journals may be misleading to readers- study highlights 3 types of confusing outcome measures AMer J Roengenology: Whole-Body MRI at Initial Diagnosis of Lymphoma - a non-ionizing modality, may be useful as an alternative to PET/CT in the malignant lymphoma. " === Videos / Webcasts Youtube: Learn about the importance of a specific subtype diagnosis in adults with NHL in this video, led by Dr. Sweetenham. === Advocacy and Notices LLS: Understanding Your Treatment Options Telephone or web conference 9/14 PAL: Our Letter to CMS on need to amend reimbursement policy for radioimmunotherapy PAL endorses Betsy de Parry's Petition PAL: Drug Shortages and How to Address! MSNBC: High price tag for treatment with new cancer drug for anaplastic large cell lymphoma The Week: The 'amazing' cancer treatment that costs $100,000 A slew of new drugs are powerfully effective at fighting cancer. NY Times: An Insurance Maze for U.S. Doctors Oncology Times: Oncology Drug Shortages Worsening, Threatening Patient Care NY Times: U.S. Scrambling to Ease Shortage of Vital Medicine Oncology Times: MUSINGS OF A CANCER DOCTOR: The Cost of Drugs MSNBC: Does Gov. 's use of an unproven stem cell 'treatment' send wrong message? Fixing the Drug Shortage: It's About Time By Raghavan, MD, PhD Snip: " ly, I don't know how the hematologists who treat blood cancers can sleep at night. " === Clinical Trials 7 Reasons to Consider Clinical Trials: based on your clinical circumstances Lymphoma Studies sponsored by CALGB cooperative group - now called the ALLIANCE === PAL Updates Words of encouragement for lymphoma patients Watchful waiting for indolent lymphomas Exercise - just " do it " How indolent Lymphomas are Monitored Comments on Programming T-cells to Kill Malignant B-Lymphocytes To Port or Not to Port - and related drug administration questions (draft) PET scan - clinical use " very little is certain and agreed upon. " === Food for Thought MD.Com: Are doctors to blame for long waiting room times? Cancer Research UK: UK Government releases new cancer patients' waiting time stats MD: The entire approach to food based on nutrients is wrong Oncology Times: Speak Up: 8 Words & Phrases to Ban in Oncology! Oncology Times: Lymphoma Expert Calls for more Focus in Clinical Respectful Insolence: The complexity of cancer, Part 1 Part 2: Enter the quacks Respectful Insolence: If we can put a man on the moon, why can't we cure cancer? === Technical and Theory and Preclinical Medical News Today: KRN5500 For Chemotherapy-Induced Neuropathic Pain Gets Fast Track Designation By FDA Medical News Today: On Trail Of A Treatment For Cancer Of The Immune System 7th Space Interactive: Subtype Distribution of Lymphomas in Southwest China: (for our readers in China) Lerner Research Institute: Researchers find new hope for treatment of chronic leukemia Links posted to News and Reports: www.lymphomation.org/current.htm OR www.facebook.com/lymphomation.PAL (requires facebook account) Stay safe! ~ Karl PATIENTS (helping-to-make-progress) AGAINST LYMPHOMA www.lymphomation.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.